Financial Results : CMCER makes SAR 10.5M profit in 2025; Q4 loss at SAR 1.3M

CMCER makes SAR 10.5M profit in 2025; Q4 loss at SAR 1.3M

01/03/2026 Argaam Exclusive

View other reports

Canadian Medical Center Co. (CMCER) reported a net profit of SAR 10.5 million in 2025, a 2.2% growth from SAR 10.3 million a year earlier.



Financials (M)

Item 2024 2025 Change‬
Revenues 110.80 148.23 33.8 %
Gross Income 28.45 43.49 52.9 %
Operating Income 11.67 18.11 55.2 %
Net Income 10.27 10.50 2.2 %
Average Shares 77.00 77.00 -
Earnings Per Share before unusual items (Riyals) 0.13 0.26 92.4 %
EPS (Riyal) 0.13 0.14 2.2 %

Revenues increased to SAR 148.2 million, up 34% year-on-year, as the company secured contracts through its branches in Jubail, Riyadh, and Tabuk, leading to a wider customer base and strengthening presence in the targeted markets.

 

CMCER won new government tenders, which supported sales volume and contributed to increasing revenues.

 

However, 2025 earnings were impacted by several non-operating factors. The company recorded non-recurring and one-off expenses from the transition to the Main Market, in addition to investment portfolio losses resulting from market conditions.



Current Quarter Comparison (M)

Compared With The
Item Q4 2024 Q4 2025 Change‬
Revenues 30.36 44.20 45.6 %
Gross Income 9.77 13.72 40.4 %
Operating Income 5.00 2.86 (42.8 %)
Net Income 4.47 (1.26) (128.3 %)
Average Shares 77.00 77.00 -
Earnings Per Share before unusual items (Riyal) 0.06 0.06 (5.1 %)
EPS (Riyal) 0.06 (0.02) (128.3 %)

CMCER incurred a net loss of SAR 1.3 million in Q4 2025, versus a net profit of SAR 4.47 million in the prior-year period.

 

On a sequential basis, the company swung to a loss from a net profit of SAR 3.48 million in Q3 2025.

 

Total shareholders’ equity (no minority interest) amounted to SAR 96.05 million as of Dec. 31, 2025, compared to SAR 93.87 million in a year earlier period.

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.